Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Stem Cell Based Diabetes Treatment: Alan Lewis - CIRM Science Writer's Seminar

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
172 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 17, 2011

(Part 5 of 9) Alan Lewis, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. At the time of this presentation Alan Lewis was president and CEO of Novocell (now ViaCyte), a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell Inc. has two CIRM grants to help develop tools and to assemble a team of researchers who will accelerate the time it takes to get that potential therapy to the FDA for clinical trials.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more